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Oral squamous cell carcinoma (OSCC) is the 8th most common can-
cer worldwide (Amit et al., 2013). The incidence has been rising in 
recent years but despite advancements in treatment and detection 
strategies, the 5-year survival rate remains stubbornly around 50% 
(Amit et al., 2013). Cancer stem cells (CSCs) are a small population 
of cells within tumours which retain some of the features of normal 
stem cells such as slow growth rate and self-renewal but are thought 
to be those that persist, drive tumour progression and are resistant 
to therapy (Vermeulen, de Sousa e Melo, Richel, & Medema, 2012). 
It has become clear that interactions of the tumour cells with the 
surrounding stroma are important in progression. Indeed, markers 
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-1h]uom7ĹCancer stem cells are responsible for tumour progression and chem-
oresistance. Fibroblasts surrounding a tumour also promote progression and fibro-
blast activation is an independent prognostic marker in oral cancer. Cancer stem 
cells may therefore promote tumourigenesis through communication with stromal 
fibroblasts.
;|_o7vĹCancer stem cells were isolated from oral cancer cell lines by adherence to 
fibronectin or cisplatin resistance. Fibroblasts were exposed to conditioned medium 
from these cells, and the activation markers, alpha smooth muscle actin and interleu-
hbmŊѵķ;u;-vv;vv;7vbm]t!-m7 bllmo=Ѵou;v1;m1;ĺ"|;l1;ѴѴl-uh;uv-m7
smooth muscle actin were examined in oral cancer tissue using immunohistochemistry.
!;vѴ|vĹAdherent and chemoresistant cells expressed increased levels of stem cell 
markers CD24, CD44 and CD29 compared with unsorted cells. Adherent cells exhib-
ited lower growth rate, higher colony forming efficiency and increased cisplatin re-
vbv|-m1;|_-mmvou|;71;ѴѴvĺ"loo|_lv1Ѵ;-1|bm-m7m|;uѴ;hbmŊѵ;ru;vvbom;u;
increased in fibroblasts exposed to conditioned medium. In oral cancer tissue, there 
was a positive correlation between expression of αSMA and stem cell markers.
om1ѴvbomvĹAdherence to fibronectin and chemoresistance isolates stem-like cells 
that can activate fibroblasts, which together with a correlation between markers of 
both in vivo, provides a mechanism by which such cells drive tumourigenesis.
  + )  ! 	 "
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of stromal fibroblast activation such as alpha smooth muscle actin 
(αSMA) have been shown to have greater prognostic significance in 
oral cancer than features of the tumour itself (Marsh et al., 2011).
CSCs can be isolated using cell sorting utilising differential ex-
pression of a number of cell surface markers or through functional 
assays such as clonogenic potential, xenografting, efflux assays or 
aldehyde dehydrogenase activity (Islam, Gopalan, Smith, & Lam, 
2015). CSCs have been shown to be present in OSCC cell lines and 
have been identified through colony morphology or rapid adher-
ence to collagen IV (Liang et al., 2014; Locke, Heywood, Fawell, & 
Mackenzie, 2005). In this study, we have used two functional assays, 
rapid adherence to fibronectin and resistance to cisplatin, to isolate 
stem-like cells from two OSCC cells lines to determine whether such 
methods isolate distinct populations. Furthermore, we hypothesise 
these CSCs may be responsible for aberrant signalling to fibroblasts 
which may be central to tumour progression.
ƑՊ |Պ$! "	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All reagents were from Sigma, UK unless otherwise stated.
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Authenticated cells lines were obtained from ECACC, Salisbury, UK. 
H357 cells were cultured in media consisting of: Dulbecco's modified 
eagles medium (DMEM) and HAMS-F12 medium (3:1), 10% foetal bo-
vine serum (FBS), Penicillin (100 IU/ml) and Streptomycin (100 mg/
ml), Amphotericin B (2.5 µg/ml), all from Invitrogen, UK, L-Glutamine 
(2 mM), Adenine (0.18 mM), Hydrocortisone (5 µg/ml), Cholera toxin 
(1 nM), Insulin (5 µg/ml) and Epidermal growth factor (10 ng/ml). SCC4 
cells were maintained in DMEM and HAMS-F12 medium (1:1) with 10% 
FBS, and antimicrobials as above. Primary normal oral fibroblasts (NOFs) 
were derived from gingival tissue obtained with informed, written con-
sent from patients at the Charles Clifford Dental Hospital, Sheffield, 
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Sheffield Research Ethics Committee. NOFs were cultured in DMEM 
supplemented with 4.5 g/L D-glucose, 10% (v/v) FBS and antimicrobials 
as above.
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with plasma fibronectin diluted in PBS (75 µg/ml) for 1 hr at 37°C and 
then blocked for a further hour with 1% bovine serum albumin (BSA) 
in DMEM. 40,000 cells in 100 µl were added and the plate incubated 
for 10 min at 37°C. Unattached cells were removed by inversion, 
and the wells were washed twice with 100 µl DMEM. Then, 100 µl 
DMEM was added to each well followed by 20 µl of MTS solution 
Ő;ѴѴ$b|;uƖѵţķuol;]-ķ&ő-m7|_;rѴ-|;bm10-|;7-|ƒƕŦbm|_;
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M200 spectrophotometer and analysed using Magellan Software 
(Tecan UK Ltd).
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per well in their growth medium and incubated for 24 hr at 37°C. 
);ѴѴv ;u; -v_;7 b|_ 	 0;=ou; -77bm] ƐƔ µM cisplatin 
(cis-Diammineplatinum (II) dichloride) to triplicate wells and incu-
bating for 24 hr at 37°C. Then, wells were washed in DMEM and 
100 μl of growth medium was added to each well and incubated 
=ouƔ7-v-|ƒƕŦĺ);ѴѴv;u;-v_;7|b1;=oѴѴo;70|_;-7-
dition of 100 μl DMEM and 20 μl of MTS solution for 1 hr at 37°C. 
The absorbance was then measured at 492 nm as above.
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a density of 10,000 cells in 100 μl of their growth medium per well 
and were incubated at 37°C. At 24-hr intervals, one of the plates was 
removed, wells washed twice with DMEM followed by the addition 
of 100 μl DMEM and 20 μl MTS solution and the plate was incubated 
for 1 hr at 37°C. The absorbance of each well was measured as above.
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Early adherent cells or unsorted cells were plated at 500 cells/ml 
growth medium and incubated for 14 days at 37°C with a medium 
1_-m];7;;uƒ7-vĺ);ѴѴv;u;|_;m-v_;7b|_"|b1;-m7
colonies fixed in 4% paraformaldehyde in PBS for 30 min at room 
temperature. Colonies were stained with methylene blue (5 mg/ml) 
in distilled water for 1 min. Excess stain was washed away and the 
plate left to dry. Images were captured, and numbers of colonies 
were counted for each well.
ƑĺѵՊ|ՊѴo1|ol;|u
Cells were detached from flasks using Accutase (BioLegend), re-
suspended in flow buffer (PBS containing 10% FCS), adjusted to a 
density of 1 × 10ѵ cells/ml and kept on ice. FITC conjugated mouse 
monoclonal anti-human CD24 (BD Pharmingen, UK, 1/5 dilution), 
FITC conjugated mouse monoclonal anti-human CD29 (integrin-β1) 
(Life Technologies Ltd., 1/20 dilution) and PE conjugated mouse 
mono-clonal anti-human CD44 antibody (BD Pharmingen, 1/5 dilu-
tion) were added for 1 hr on ice in the dark with the absence of anti-
body serving as a negative control. Cells were then washed, and the 
pellet re-suspended in cold flow buffer on ice. Finally, median fluo-
rescence expression of CD24, CD44 and CD29 was quantified using 
a FACS Calibur machine and CellQuest software (BD Biosciences).
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RNA was extracted using RNeasy mini kits (Qiagen) and genomic 
DNA digested using RNase free DNase (27KU/sample). cDNA was 
synthesised using a high capacity cDNA reverse transcription kit 
(Thermo Fisher). Tubes were then placed into a thermal cycler (BIO-
RAD) and run at 25°C for 10 min, 37°C for 2 hr and 85°C for 5 min. 
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The following genes were targeted using SYBR green primers from 
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B2M as an endogenous control (Hs00982282). Assays were performed 
in triplicate on a Rotor-Gene Q real-time PCR machine (QIAGEN). The 
|_;ul-Ѵ11Ѵ;1omvbv|;7o=ƒv|-];vĹƖƔŦ=ouƐƏvķѵƏŦ=ouƐƔv-m7
72°C for 20 s for 40 cycles. Rotor-Gene 2.1.0.9 software programme 
(QIAGEN) was used to analyse cycle threshold (Ct) values for all samples, 
and the qPCR data were quantified using the ΔΔCt method.
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A total of 10 cases of moderate grade oral squamous cell carcinoma 
(Table 1) were obtained from the School of Clinical Dentistry under 
the ethical approval number 07/H1309/150 (Sheffield Research 
Ethics Committee). Sections (4 μm) were de-waxed in xylene fol-
lowed by 100% ethanol. Slides were incubated for 20 min in 3% (v/v) 
hydrogen peroxide in 100% methanol (all Fisher Scientific) and anti-
gen retrieval performed by microwaving at full power (Panasonic NN-
ƑƔƑ)őbmƏĺƏƐvo7bl1b|u-|;=ouѶlbmĺ"Ѵb7;v;u;-v_;7-m7
cooled in PBS and blocked in 100% horse serum at room temperature 
for 30 min. The serum was removed and primary mouse monoclo-
nal antibodies in horse serum (1/100 v/v) added in a humidified at-
mosphere overnight at 4°C. The antibodies used in this study were: 
anti-CD24 antibody (2 μ]ņlѴķ-0ƒƐѵƑƑőķ-m|bŊ	ƓƓ-m|b0o7ŐƏĺƔμg/
ml, ab9524), anti-α-SMA antibody (10 μg/ml, ab7817, all Abcam). 
Slides were washed, and mouse biotinylated secondary antibody and 
Avidin Biotinylated enzyme Complex (VECTASTAINţ Elite, Vector 
Laboratories) was prepared and added. DAB (3,3-diaminobenzidine 
tetrahydrochloride, Vector) was the added until a dark brown precipi-
tate appeared. The slides were transferred to distilled water, counter-
stained with haematoxylin and mounted using DPX (Fisher).
Slides were digitally scanned using Aperio ScanScop (Leica 
Biosystems) and were archived and viewed using e.slide manager 
Digital Pathology software. Six images at the same magnifica-
tion were captured for regions of interest (ROI) of the tumour in-
vasive front regions in each tumour section slide using the Aperio 
l-];"1or;vo=|-u;Ő;b1-ő-m7|_;=u;;_-m7|ooѴo=l-];vo=|-
ware was used to select and analyse the specific ROI to determine 
the percentage of antibody staining.
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Cells were seeded at a density of 5,000 cells on glass coverslips 
(Fisher Scientific) in 1 ml of their growth medium in a 24-well plate 
for 48 hr at 37°C. Coverslips were washed with PBS, fixed with 
100% methanol (Fisher) for 15 min, permeabilised with 4 mM so-
dium deoxycholate in PBS for 15 min and incubated with block-
ing buffer (25 µg/ml BSA in PBS) for 30 min at room temperature. 
0.2 ml of FITC conjugated anti-alpha smooth muscle actin (α-SMA) 
antibody (1:100 dilution, Clone A.4) was added for 1 hr at room 
$     Ɛ Պ Clinical and histopathological data of patients and tumours in the selected study sample
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1 88 F 34 10 Disc Mod No No Close Yes Yes
2 ѵѶ 18 5.5 Coh Poor No No Clear Yes No
3 ѵƒ 30 23 Disc Mod No Yes Invol Yes No
4 79 M 30 17 Disc Poor Yes No Close Yes No
5 55 F 12 1.5 Coh Poor No No Invol Yes No
ѵ 42 F 30 12.5 Disc Poor Yes No Close Yes Yes
7 70 F 49 11.5 Disc Mod No Yes Close Yes Yes
8 71 M ѵƑ 20 Coh Mod No No Invol Yes Yes
9 91 M 14 ѵ Disc Strong No No Clear Yes Yes
10 72 F 50 8 Disc Mod Yes No Close Yes Yes
Note: All tumours were of moderate grade.
Abbreviations: Coh, cohesive; Disc, discohesive; ECS, extra capsular spread; F, female; Invol, involved; M, male; Mod, moderate.
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temperature. Coverslips were washed and mounted with ProlongTM 
Diamond mountant with DAPI (Thermo Fisher). Slides were viewed 
and images captured using a fluorescent microscope (Axioplan 2 
and image-ProPlus 7.0.1 software, Zeiss). The level of fluorescent 
v|-bmbm]-vt-m|b=b;7vbm]l-];vo=|-u;Ő;uvbomƐĺƔƑķķ
USA).
ƑĺƐƏՊ|Պb0uo0Ѵ-v|-1|b-|bom
OSCC cells were seeded at a density of 200,000 cells per well and 
incubated at 37°C for 24 hr. Cells were washed twice and 1 ml 0.5% 
FCS in DMEM: F12 (3:1) was added and incubated at 37°C for 48 hr. 
Normal oral fibroblasts (NOFs) were plated onto sterile coverslips 
   & !   Ɛ Պ Expression of stem cells markers by unsorted OSCC cells and those sorted using early adherence to fibronectin or 
chemoresistance to cisplatin determined using flow cytometry. Cell surface expression of CD24, CD44 and CD29 by early adherent H357 
(a-c) and SCC4 cells (d-f). Cell surface expression of CD24, CD44 and CD29 by chemoresistant H357 (g-i) and SCC4 cells (j-l). n = 3, *p < .05, 
**p < .01, ***p < .001
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in growth medium at 5,000 cells/well for immunofluorescence and 
100,000 cells/well for qPCR. Conditioned medium from OSCC cells 
was centrifuged at 300 g for 10 min to remove any cells. Medium 
was removed from the NOFs, and 1 ml conditioned medium from 
isolated and unsorted OSCC cells was added. In addition, medium 
containing 10 ng/ml human recombinant TGF-β1 (R&D Systems) was 
used as a positive control and medium alone as a negative control. 
The plates were then incubated at 37°C for 48 hr.
ƑĺƐƐՊ|Պ"|-|bv|b1-Ѵ-m-Ѵvbv
Unless otherwise stated, all experiments were performed three 
times in triplicate (n = 3). GraphPad Prism, version 7 software was 
used for analysis and comparisons made using unpaired two tailed 
Student's t test with a p value <.05 considered significant. Simple 
linear regression was used to test the statistical significance of data 
correlations.
ƒՊ |Պ!"&$"
H357 and SCC4 cells isolated by adherence to fibronectin for 10 min 
exhibited significantly higher surface protein levels of the stem 
cell markers CD24, CD44 and CD29 compared with unsorted cells 
(Figure 1a-f). This was also the case for cells that were resistant to cis-
platin (Figure 1g-l). Expression of these stem cell marker genes using 
qPCR was similarly significantly increased in early adherent and chem-
oresistant cells from both lines (Figure 2a-d). Isolated cell populations 
also displayed functional characteristics of stem cells with reduced 
growth rate (Figure S1) and an enhanced ability to form colonies 
(Figure 3a,b).
Our two functional methods of separating stem cells ap-
peared to be isolating a similar population as rapidly adherent cells 
were more resistant to cisplatin than unsorted cells (Figure 3c,d), 
and chemoresistant cells were more adherent to fibronectin 
(Figure 3e,f).
Conditioned media from early adherent and chemoresistant 
cells from both cells lines resulted in an upregulation of both 
α"-m7Ŋѵ];m;;ru;vvbombmmoul-Ѵou-Ѵ=b0uo0Ѵ-v|v|o-vbl-
ilar degree (Figure 4). The effect on αSMA expression was how-
ever not as large as that of the well described effects of TGF-β1 
on this gene (Figure 4a-d). In this study, treatment with TGF-β1 
7b7 mo| u;vѴ| bm -m bm1u;-v; bm Ŋѵ ];m; ou ruo|;bm ;ru;vvbom
(Figure 4e-h). Protein expression of αSMA was similarly affected 
in fibroblasts treated with the conditioned medium from early ad-
herent and chemoresistant cells with strong fluorescent intracel-
lular stress fibre staining visible in these but not cells treated with 
unsorted cell conditioned medium (Figure 5a-d). Quantification of 
the fluorescence intensity revealed that for bot cell lines condi-
tioned medium from isolated cell was able to elicite a response 
similar to that of TGF-β1 (Figure 5g,j).
Immunohistochemical analysis of CD24 and CD44 was per-
formed in OSCC tissue and showed expression of both throughout 
|lou;rb|_;Ѵbl-m7bvѴ-m7vŐ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expression of both stem cell markers correlated closely with expres-
sion of α"bm|_;|louv|uol- Őb]u;ѵ0ķ7ķ;ő-v;ѴѴ-vb|_
;-1_o|_;uŐb]u;ѵ=őĺ
   & !   Ƒ Պ Gene expression of 
stem cell markers by OSCC cells sorted 
using early adherence to fibronectin or 
chemoresistance to cisplatin determined 
using quantitative PCR. Fold change 
relative to gene expression in unsorted 
cells shown for early adherent H357 (a) 
and SCC4 cells (b) and chemoresistant 
H357 (c) and SCC4 cells (d). n = 3, *p < .05, 
**p < .01, ***p < .001, ****p < .0001
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Our data showed rapid adhesion to fibronectin and resistance to 
cisplatin in a sub population of cells from the OSCC lines H357 and 
"Ɠĺ);1_ov;|_;v;-vv-v0-v;7om|_;=-1||_-||_;-u;0o|_
functional in nature and do not purely relate to expression of stem 
cell markers. Previous studies have predicted that the percentage 
of stem cells is less than 10% of the total unfractionated keratino-
1|;v Őom;vķ -ur;uķ )-||ķ ş ;ķ ƐƖƖƔĸ o||;m ş ouubvķ ƐƖѶѶő
which is in accordance with our study. In data not shown, we have 
demonstrated that both these cell lines are much more adherent 
to collagen I which is agreement with previous work suggesting 
that this matrix protein has limited use in isolating stem cells as 
most basal layer keratinocytes rapidly adhere (Kaur & Li, 2000). 
Isolated populations of cells (early adherent and chemoresistant) 
from the both oral cancer cell lines tested expressed significantly 
higher levels of integrin-β1 (CD29) compared with unsorted cells 
which, as this is a receptor for fibronectin, may explain their en-
hanced adherence.
To characterise the isolated population of cells, we selected 
three of the most common head and neck squamous cell carcinoma 
stem cell surface markers CD44 (hyaluronate receptor), CD24 
(specific ligand of P-selectin receptor) and CD29 (integrin-β1). 
Our selection of multiple markers was motivated by the lack of a 
universal or single specific marker for CSCs, and there is variation 
in the most appropriate markers to best distinguish CSCs from non-
CSCs populations in different tumour type (Tirino et al., 2013). Our 
findings from FACS and gene expression analysis showed that the 
isolated cells expressed significantly increased levels of all inves-
tigated stem cell surface markers (CD24, CD44 and CD29) com-
pared with that of unsorted cells. This is consistent with studies by 
Han, Fujisawa, Husain, & Puri (2014) which showed a population 
of CD24+/CD44+ head and neck squamous cell carcinoma cells 
expressed higher levels of CD29 and possessed stemness char-
acteristics. In addition, low proliferation rate but enhanced colony 
forming ability is considered important in vitro functional assays 
for characterising of CSCs (Franken, Rodermond, Stap, Haveman, 
ş(-mu;;ķƑƏƏѵĸ!o;v1_;|-ѴĺķƑƏƐƏőĺuu;vѴ|vbm7b1-|;7-u;-
duced growth rate of sorted cell subpopulations compared with 
unsorted cells in both OSCC cell lines. Furthermore, early adherent 
cells showed a significantly higher clonogenic potential compared 
with unsorted cells, which is in agreement with previous studies on 
HNSCC adhesion to collagen IV (Liang et al., 2014).
Our findings that early adherent cells of both cancer cell lines 
were more resistant to cisplatin in comparison with unsorted cells 
and vice versa suggests that we have isolated a similar population 
of cells. Previous studies found enhanced cisplatin chemoresistance 
in cancer cells with increased adhesion to fibronectin (Hartmann, 
   & !   ƒ Պ Colony forming ability of 
early adherent H357 (a) and SCC4 cells 
(b) compared with unsorted cells. Cell 
viability of early adherent H357 (c) and 
SCC4 cells (d) following exposure to 
cisplatin compared with unsorted cells. 
Early adhesion of chemoresistant H357 (e) 
and SCC4 cells (f) to fibronectin compared 
with unsorted cells. n = 3, *p < .05, 
**p < .01, ***p < .001, ****p < .0001
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Burger, Glodek, Fujii, & Burger, 2005; Nakahara et al., 2003), pos-
sibly mediated by α5β1 integrin survival signals inhibiting apoptosis. 
Vallo et al. (2017) reported upregulated levels of β1 integrin in cispla-
tin-resistant urethral cancer cell lines.
Cancer cells secrete cytokines and growth factors that medi-
ate fibroblast activation into cancer-associated fibroblasts (CAFs), 
which is considered an early and important event in tumourgene-
sis (Beacham & Cukierman, 2005; Liotta & Kohn, 2001). To investi-
gate whether the isolated CSCs signal differently to fibroblasts, we 
analysed expression of two genes commonly upregulated in CAFs: 
αŊ"-m7ŊѵŐoѴ|;|-ѴĺķƑƏƐѶĸmŊ"1_]_-u|şm;1_;ѴķƑƏƏƑő
upon exposure to condition media from isolated cells. Our results 
revealed upregulation of both markers (αŊ" -m7 Ŋѵő _;m =b-
broblasts were incubated with conditioned media collected from 
isolated cells (early adherent and chemoresistant) for the both ex-
amined oral cancer cell lines (H357 and SCC4) in comparison with 
conditioned media of unsorted cells. To our knowledge, this obser-
vation has not been previously reported.
Normal lung fibroblasts incubated with conditioned media 
from cancer cells treated with cisplatin showed an increased 
-1|b-|bom o= |_;v; =b0uo0Ѵ-v|v bm|o v Ő"_bm|-mb ;| -Ѵĺķ ƑƏƐѵőĺ
This is similar to our findings that normal oral fibroblasts incu-
bated with conditioned media collected from chemoresistant cells 
were activated and expressed intense α-SMA staining as well as 
upregulated CAF markers. Integrin pathways (α5β1 and αvβѵő
also regulate and induce TGF-β1 in oral and dermal fibroblasts 
Ő]o;ķ)-ѴѴķ"|;r_;mvķş;bvķƑƏƏƕőĺ$_;u;=ou;ķ|_;-1|b-|bom
of fibroblasts incubated with condition media of isolated cells 
could be attributed to stimulation of integrin-β1 receptors that 
may result in higher TGF-β1 which in turn increases activation 
of normal oral fibroblasts into CAFs. Integrin-β1 receptors may 
also mediate costimulatory signals that required for inflammatory 
cytokine gene expression and subsequent production of inflam-
matory cytokines (Miyake et al., 1993). Several studies reported 
that some inflammatory cytokines are secreted by cancer cells 
induce the activation of stromal fibroblasts into CAFs (Giannoni 
   & !   Ɠ Պ Fold change in α-smooth 
muscle actin gene expression determined 
by quantitative PCR in normal human oral 
fibroblasts (NOFs) following exposure 
to conditioned media from unsorted and 
early adherent H357 (a) and SCC4 cells (b) 
and chemoresistant H357 (c) and SCC4 
cells (d) along with TGF-β1 (10 ng/ml). Fold 
1_-m];bmbm|;uѴ;hbmŊѵ];m;;ru;vvbom
determined by quantitative PCR in normal 
human oral fibroblasts (NOFs) following 
exposure to conditioned media from 
unsorted and early adherent H357 (e) and 
SCC4 cells (f) and chemoresistant H357 
(g) and SCC4 cells (h). n = 3, *p < .05, 
**p < .01, ***p < .001, ****p < .0001
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et al., 2010; Paland et al., 2009). Therefore, it may be that acti-
vation of NOFs exposed to conditioned media from isolated cells 
bv7;|oruoŊbm=Ѵ-ll-|ou1|ohbm;vv1_-vŊѵķŊѶ-m7ŊƐβ 
(Doldi et al., 2015).
Previous studies have reported that cells with co-expression 
of CD24 and CD44 were confirmed as CSCs in different types of 
cancer, including head and neck squamous cell carcinoma (Han 
et al., 2014). Our results revealed a significant positive correlation 
between the expression of CD24 and CD44 markers in oral 
squamous cell carcinoma. Our findings demonstrated a positive 
correlation between the expression of both CSC markers CD24 
and CD44 in the tumour and the expression of α-SMA in stroma. 
This correlation has not been previously reported and suggests 
that our findings in vitro may also be of relevance in vivo. Studies 
conducted on OSCC indicate that epithelial cancer cells induced 
the activation of stroma and increased expression of stromal 
   & !   Ɣ Պ Expression of α-smooth 
muscle actin by fluorescence 
immunocytochemistry in unsorted H357 
(a) and SCC4 (c) cells compared with early 
adherent H357 (b) and SCC4 cells (d) 
and chemoresistant H357 (e) and SCC4 
cells (f). Representative images of n = 2 
shown, bar = 100 µm. Quantification of 
fluorescence intensity in early adherent 
(g) and chemoresistant (h) H357 (open 
squares) and SCC4 cells (filled squares). 
Expression in media treated fibroblasts 
(negative control) is compared with those 
exposed to TGF- β1 (10 ng/ml) (positive 
control) and conditioned media from 
unsorted and sorted cells (n = 2)
(a) (b)
(c) (d)
(e) (f)
(g) (h)
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α-SMA (Etemad-Moghadam, Khalili, Tirgary, & Alaeddini, 2009; 
u-v-7 ;| -Ѵĺķ ƑƏƐѵőĺ u|_;ulou;ķ |_;u; bv - vb]mb=b1-m| rovb|b;
link between α-SMA expression in the tumour stroma and the 
increasing invasiveness and subsequent poor prognosis of OSCC 
(Dourado, Guerra, Salo, Lambert, & Coletta, 2018; Kellermann 
et al., 2007). Similarly, many studies correlated the elevated ex-
pression of CD24 and CD44 stem cell markers in oral squamous 
cell carcinoma with an increasing in tumour progression, aggres-
siveness, invasion and metastasis. Han et al. (2009) reported 
CD24 and CD44 expression as important diagnostic markers for 
OSCC. Expression of CD44, CD24 and CD29 correlates with the 
increased growth rate and resistance to radiotherapy in head and 
neck squamous cell carcinoma (Koukourakis, Giatromanolaki, 
Tsakmaki, Danielidis, & Sivridis, 2012; Oliveira et al., 2011) and 
poor overall survival outcomes in patients with OSCC (de Moraes 
et al., 2017). Abdulmajeed, Dalley, and Farah (2013) considered 
increased expression of CD24 a potent diagnostic marker for de-
tection of oral epithelial dysplasia and OSCC.
); _-; 7;lomv|u-|;7 |_-| - rorѴ-|bom o= 1;ѴѴv ;ru;vvbm]
stem cell markers and functional properties can be isolated for 
oral cancer cell lines using either rapid adherence to fibronectin 
or resistance to cisplatin. Secreted factors from these cells can 
activate normal oral fibroblasts as demonstrated by upregulated 
α"-m7Ŋѵ;ru;vvbomĺ|l-|_;u;=ou;0;|_;1-v;|_-|1-m-
cer stem cells drive tumour progression through effects on the 
surrounding tumour stroma.
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   & !   ѵ Պ Immunohistochemical 
expression of CD24 (a), CD44 (c) and 
αSMA (e) in a representative OSCC 
tissue sample along with the correlation 
of expression analysis in all 10 cases of 
OSCC for CD24 and αSMA (b), CD44 
and αSMA (d) and CD24 and CD44 (f). 
Bar = 200 µm
(a) (b)
(c) (d)
(e) (f)
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